This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $70.12, moving -1.52% from the previous trading session.
Walgreens Boots Alliance (WBA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $71.88, moving -0.53% from the previous trading session.
Microsoft a Must Buy Ahead of Q2 Earnings
by Tirthankar Chakraborty
Addition of cloud computing is expected to help Microsoft continue its impressive record with respect to beating earnings estimates.
Can Rite Aid's (RAD) Reverse Stock Split Plan Aid Stock?
by Zacks Equity Research
Rite Aid (RAD) plans a reverse stock split to lift the stock price and regain compliance under NYSE listing rules.
Alphabet ECG Feature OK'd by FDA, Healthcare Plans on Track
by Zacks Equity Research
Alphabet's (GOOGL) Verily scores FDA clearance for its electrocardiogram technology (ECG) in its Study Watch.
Walgreens (WBA) Up 4.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Walgreens (WBA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $72.30, moving +0.43% from the previous trading session.
Dow 30 Stock Roundup: JPM & AXP Earnings Disappoint, GS & UNH Impress
by Swarup Gupta
The index enjoyed another strong week of gains, increasing over three straight sessions.
Microsoft, WBA Deal to Break AMZN, GOOGL Healthcare Dreams
by Zacks Equity Research
Microsoft (MSFT) inks a seven-year deal with Walgreens to offer innovative healthcare delivery solutions that can pose threat to Amazon and Google's growing presence.
Amazon Fear Grips Retail Pharmacy Space, Alliances Continue
by Urmimala Biswas
While Amazon is figuring out ways to expand in the multibillion dollar pharmacy industry, Walgreens and other industry players are ready to counter competition.
Bull of the Day: Lululemon (LULU)
by Benjamin Rains
This sportswear firm just raised its Q4 guidance and looks poised for success in a growing athleisure market.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
PPI Joins Q4 Reports for JPM, WFC & More; Big Day for Data
by Mark Vickery
Currently, Q4 earnings season is heating up in earnest, with two top Wall Street banks and two other sector leaders bringing results ahead of the opening bell.
Lululemon (LULU) Stock Looks Like a Buy & It Just Raised Its Q4 Guidance
by Benjamin Rains
Shares of Lululemon (LULU) soared as high as 8% in morning trading Monday after the yoga apparel powerhouse raised its Q4 earnings and revenue guidance.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $71.71 in the latest trading session, marking a -1.06% move from the prior day.
Kroger, Microsoft Partner for Connected Store Pilot Program
by Zacks Equity Research
Kroger (KR) collaborates with Microsoft to leverage RaaS in enhancing customer's online shopping experience, using the latter's cloud based platform.
Pharmacies & Drug Stores Industry Outlook: Prospects Look Weak
by Zacks Equity Research
Pharmacy retailers are gradually realizing the growing market demand for Medicare plan options. This apart, they are aggressively emphasizing on chronic disease care and management.
Walgreens Boots Alliance (WBA) Stock Moves -1.04%: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $67.33, moving -1.04% from the previous trading session.
Walgreens Counts on International Progress, Strategic Deals
by Zacks Equity Research
We are upbeat about Walgreens' (WBA) recent pact with Alphabet???s life sciences and healthcare segment, Verily, to coordinate on multiple projects with respect to chronic ailments.
Zacks Investment Ideas feature highlights: Tesla, Walgreen Boots Alliance and Oracle
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Tesla, Walgreen Boots Alliance and Oracle
Why Did Tesla (TSLA) Stock Climb Today?
by Ryan McQueeney
Shares of Tesla (TSLA) added nearly 5% on Friday after the company announced the appointment of Larry Ellison and Kathleen Wilson-Thompson to its board of directors.
Positive Management Changes Boost Tesla Shares
by David Borun
Kathleen Wilson-Thompson and Larry Ellison strengthen the Board of Directors at Tesla
Walgreens Boots Alliance (WBA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $68.36, marking a +0.95% move from the previous day.
Amazon Posts Record-Breaking Holiday Sales: Time to Buy AMZN Stock?
by Benjamin Rains
Shares of Amazon (AMZN) popped 5% in morning trading the day after Christmas after the e-commerce powerhouse said that its customers made more purchases worldwide than ever before during the holiday season. The question now is should investors consider buying Amazon stock on the dip as we move into 2019?
5 Worst Performing Stocks of Dow ETF Last Week
by Sweta Killa
Dow Jones suffered its worst week since the global financial crisis of 2008. We have highlighted five worst-performing stocks in the ETF.